Age at Menarche and Menopause and Breast Cancer Risk in the International BRCA1/2 Carrier Cohort Study
Open Access
- 1 April 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 16 (4), 740-746
- https://doi.org/10.1158/1055-9965.epi-06-0829
Abstract
Background: Early menarche and late menopause are important risk factors for breast cancer, but their effects on breast cancer risk in BRCA1 and BRCA2 carriers are unknown. Methods: We assessed breast cancer risk in a large series of 1,187 BRCA1 and 414 BRCA2 carriers from the International BRCA1/2 Carrier Cohort Study. Rate ratios were estimated using a weighted Cox-regression approach. Results: Breast cancer risk was not significantly related to age at menopause {hazard ratio [HR] for menopause below age 35 years, 0.60 [95% confidence interval (95% CI), 0.25-1.44]; 35 to 40 years, 1.15 [0.65-2.04]; 45 to 54 years, 1.02 [0.65-1.60]; ≥55 years, 1.12 [0.12-5.02], as compared with premenopausal women}. However, there was some suggestion of a reduction in risk after menopause in BRCA2 carriers. There was some evidence of a protective effect of oophorectomy (HR, 0.56; 95% CI, 0.29-1.09) and a significant trend of decreasing risk with increasing time since oophorectomy, but no apparent effect of natural menopause. There was no association between age at menarche and breast cancer risk, nor any apparent association with the estimated total duration of breast mitotic activity. Conclusions: These results are consistent with other observations suggesting a protective effect of oophorectomy, similar in relative effect to that in the general population. The absence of an effect of age at natural menopause is, however, not consistent with findings in the general population and may reflect the different natural history of the disease in carriers. (Cancer Epidemiol Biomarkers Prev 2007;16(4):740–6)Keywords
This publication has 19 references indexed in Scilit:
- Breast Cancer Risk Following Bilateral Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: An International Case-Control StudyJournal of Clinical Oncology, 2005
- Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersCancer Causes & Control, 2005
- Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal PhenotypeClinical Cancer Research, 2005
- Contralateral Breast Cancer in BRCA1 and BRCA2 Mutation CarriersJournal of Clinical Oncology, 2004
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesAmerican Journal of Human Genetics, 2003
- Risk-Reducing Salpingo-oophorectomy in Women with aBRCA1orBRCA2MutationNew England Journal of Medicine, 2002
- Prophylactic Oophorectomy in Carriers ofBRCA1orBRCA2MutationsNew England Journal of Medicine, 2002
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997
- Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: Associations and interactions in an international case‐control studyInternational Journal of Cancer, 1990
- The Robust Inference for the Cox Proportional Hazards ModelJournal of the American Statistical Association, 1989